MA26587A1 - Composes de triazine - Google Patents

Composes de triazine

Info

Publication number: MA26587A1
Authority: MA; Morocco
Prior art keywords: triazine compounds; triazine; compounds
Prior art date: 1997-12-22

Application number

MA25403A

Other languages

English (en)

Inventor

Patrick Healy Mark

Punjabhai Shah Gita

Cox Brian

Stuart Nobbs Malcom

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-22

Filing date

1998-12-22

Publication date

2004-12-20

1998-12-22 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2004-12-20 Publication of MA26587A1 publication Critical patent/MA26587A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA25403A 1997-12-22 1998-12-22 Composes de triazine MA26587A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9726987.2A GB9726987D0 (en)	1997-12-22	1997-12-22	Compounds

Publications (1)

Publication Number	Publication Date
MA26587A1 true MA26587A1 (fr)	2004-12-20

Family

ID=10823992

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25403A MA26587A1 (fr)	1997-12-22	1998-12-22	Composes de triazine

Country Status (34)

Country	Link
US (2)	US6265405B1 (fr)
EP (1)	EP1042304A1 (fr)
JP (1)	JP2001526275A (fr)
KR (1)	KR20010024800A (fr)
CN (1)	CN1284951A (fr)
AP (1)	AP2000001846A0 (fr)
AR (1)	AR014146A1 (fr)
AU (1)	AU753874B2 (fr)
BR (1)	BR9814495A (fr)
CA (1)	CA2315620A1 (fr)
CO (1)	CO5011066A1 (fr)
EA (1)	EA200000561A1 (fr)
EE (1)	EE200000391A (fr)
GB (1)	GB9726987D0 (fr)
GT (1)	GT199800203A (fr)
HN (1)	HN1998000193A (fr)
HR (1)	HRP20000419A2 (fr)
HU (1)	HUP0100611A3 (fr)
ID (1)	ID25449A (fr)
IL (1)	IL136867A0 (fr)
IS (1)	IS5542A (fr)
JO (1)	JO2065B1 (fr)
MA (1)	MA26587A1 (fr)
NO (1)	NO20003211L (fr)
NZ (1)	NZ505254A (fr)
PA (1)	PA8465101A1 (fr)
PE (1)	PE20000063A1 (fr)
PL (1)	PL341392A1 (fr)
SK (1)	SK9592000A3 (fr)
SV (1)	SV1998000151A (fr)
TR (1)	TR200001970T2 (fr)
WO (1)	WO1999032462A1 (fr)
YU (1)	YU39600A (fr)
ZA (1)	ZA9811725B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0002666D0 (en)	2000-02-04	2000-03-29	Univ London	Blockade of voltage dependent sodium channels
SI1458386T1 (sl) *	2001-12-27	2007-08-31	Ortho Mcneil Pharm Inc	Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema
KR100882707B1 (ko) *	2002-07-29	2009-02-06	글락소 그룹 리미티드	라모트리진을 포함하는 서방형 제제
EP1596844A2 (fr) *	2003-01-30	2005-11-23	Dynogen Pharmaceuticals Inc.	Methodes destinees a traiter les troubles du tractus gastro-intestinal au moyen de modulateurs du canal sodique
AR044503A1 (es)	2003-03-18	2005-09-14	Merck & Co Inc	Triazoles sustituidos con biarilo como bloqueantes del canal de sodio
DE10332472A1 (de) *	2003-07-16	2005-02-03	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ambroxol für die Behandlung von Tinnitus
US20070276046A1 (en) *	2003-08-25	2007-11-29	Patricia Salvati	Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents
US20060115865A1 (en) *	2004-10-25	2006-06-01	Anlong Ouyang	Lamotrigine analogs
GB201111712D0 (en)	2011-07-08	2011-08-24	Gosforth Ct Holdings Pty Ltd	Pharmaceutical compositions
EP3524605B1 (fr) *	2018-02-13	2019-11-27	F.I.S.- Fabbrica Italiana Sintetici S.p.A.	Nouveau procédé efficace pour la préparation de sitagliptine
CN114796146B (zh) *	2022-04-28	2023-03-28	上海奥科达医药科技股份有限公司	一种拉莫三嗪的缓释制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3637688A (en)	1970-01-09	1972-01-25	American Home Prod	6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
EP0021120B1 (fr)	1979-06-01	1983-04-06	The Wellcome Foundation Limited	Dérivés de la diamino-3,5 triazine-1,2,4, procédé pour la préparation de tels composés et compositions pharmaceutiques les contenant
DK153787C (da)	1979-06-01	1989-01-16	Wellcome Found	Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
EP0086502B1 (fr)	1979-08-16	1987-03-25	The Wellcome Foundation Limited	Triazines aromatiques substituées
GB8328757D0 (en)	1983-10-27	1983-11-30	Wellcome Found	Chemical compounds
GB9012312D0 (en)	1990-06-01	1990-07-18	Wellcome Found	Pharmacologically active cns compounds
GB9012316D0 (en)	1990-06-01	1990-07-18	Wellcome Found	Pharmacologically active cns compounds
GB9012311D0 (en)	1990-06-01	1990-07-18	Wellcome Found	Pharmacologically active cns compounds
GB9203483D0 (en)	1992-02-19	1992-04-08	Wellcome Found	Anti-inflammatory compounds
WO1993025207A1 (fr)	1992-06-12	1993-12-23	The Wellcome Foundation Limited	Utilisation de l'isethionate de 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine pour le traitement et la prevention de la dependance, de l'accoutumance et de la sensibilite vis-a-vis de medicaments et de drogues
AU5704594A (en)	1992-12-18	1994-07-19	Wellcome Foundation Limited, The	Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
US5866597A (en)	1993-03-19	1999-02-02	Glaxo Wellcome Inc.	Use of triazine compounds for the treatment of memory and learning disorders
GB9305692D0 (en)	1993-03-19	1993-05-05	Wellcome Found	Therapeutic triazine compounds and use
GB9426448D0 (en) *	1994-12-30	1995-03-01	Wellcome Found	Process
FR2741879A1 (fr)	1995-12-05	1997-06-06	Esteve Labor Dr	Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament

1997
- 1997-12-22 GB GBGB9726987.2A patent/GB9726987D0/en not_active Ceased
1998
- 1998-12-18 BR BR9814495-2A patent/BR9814495A/pt not_active IP Right Cessation
- 1998-12-18 YU YU39600A patent/YU39600A/sh unknown
- 1998-12-18 EE EEP200000391A patent/EE200000391A/xx unknown
- 1998-12-18 US US09/582,058 patent/US6265405B1/en not_active Expired - Fee Related
- 1998-12-18 NZ NZ505254A patent/NZ505254A/en unknown
- 1998-12-18 EA EA200000561A patent/EA200000561A1/ru unknown
- 1998-12-18 SV SV1998000151A patent/SV1998000151A/es unknown
- 1998-12-18 KR KR1020007006947A patent/KR20010024800A/ko not_active Application Discontinuation
- 1998-12-18 IL IL13686798A patent/IL136867A0/xx unknown
- 1998-12-18 PL PL98341392A patent/PL341392A1/xx unknown
- 1998-12-18 EP EP98966635A patent/EP1042304A1/fr not_active Withdrawn
- 1998-12-18 CA CA002315620A patent/CA2315620A1/fr not_active Abandoned
- 1998-12-18 WO PCT/EP1998/008273 patent/WO1999032462A1/fr not_active Application Discontinuation
- 1998-12-18 JP JP2000525399A patent/JP2001526275A/ja active Pending
- 1998-12-18 AU AU24147/99A patent/AU753874B2/en not_active Ceased
- 1998-12-18 AP APAP/P/2000/001846A patent/AP2000001846A0/en unknown
- 1998-12-18 SK SK959-2000A patent/SK9592000A3/sk unknown
- 1998-12-18 TR TR2000/01970T patent/TR200001970T2/xx unknown
- 1998-12-18 CN CN98813745A patent/CN1284951A/zh active Pending
- 1998-12-18 HU HU0100611A patent/HUP0100611A3/hu unknown
- 1998-12-18 CO CO98075403A patent/CO5011066A1/es unknown
- 1998-12-18 AR ARP980106526A patent/AR014146A1/es not_active Application Discontinuation
- 1998-12-18 ID IDW20001416A patent/ID25449A/id unknown
- 1998-12-21 ZA ZA9811725A patent/ZA9811725B/xx unknown
- 1998-12-21 PA PA19988465101A patent/PA8465101A1/es unknown
- 1998-12-21 PE PE1998001255A patent/PE20000063A1/es not_active Application Discontinuation
- 1998-12-21 JO JO19982065A patent/JO2065B1/en active
- 1998-12-22 GT GT199800203A patent/GT199800203A/es unknown
- 1998-12-22 MA MA25403A patent/MA26587A1/fr unknown
1999
- 1999-12-21 HN HN1998000193A patent/HN1998000193A/es unknown
2000
- 2000-06-20 IS IS5542A patent/IS5542A/is unknown
- 2000-06-21 NO NO20003211A patent/NO20003211L/no unknown
- 2000-06-21 HR HR20000419A patent/HRP20000419A2/hr not_active Application Discontinuation
2001
- 2001-07-06 US US09/899,198 patent/US6465461B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP20000419A2 (en)	2000-12-31
PL341392A1 (en)	2001-04-09
AU753874B2 (en)	2002-10-31
CA2315620A1 (fr)	1999-07-01
PE20000063A1 (es)	2000-02-16
YU39600A (sh)	2002-11-15
HN1998000193A (es)	2000-04-05
GB9726987D0 (en)	1998-02-18
PA8465101A1 (es)	2000-09-29
TR200001970T2 (tr)	2001-01-22
SK9592000A3 (en)	2001-03-12
US6265405B1 (en)	2001-07-24
NO20003211L (no)	2000-08-21
AR014146A1 (es)	2001-02-07
EE200000391A (et)	2002-02-15
NZ505254A (en)	2002-06-28
IL136867A0 (en)	2001-06-14
EP1042304A1 (fr)	2000-10-11
CN1284951A (zh)	2001-02-21
KR20010024800A (ko)	2001-03-26
JO2065B1 (en)	2000-05-21
GT199800203A (es)	2000-06-14
EA200000561A1 (ru)	2001-04-23
JP2001526275A (ja)	2001-12-18
IS5542A (is)	2000-06-20
HUP0100611A3 (en)	2003-03-28
BR9814495A (pt)	2000-10-10
ZA9811725B (en)	2000-06-27
AU2414799A (en)	1999-07-12
CO5011066A1 (es)	2001-02-28
NO20003211D0 (no)	2000-06-21
ID25449A (id)	2000-10-05
SV1998000151A (es)	1999-07-05
AP2000001846A0 (en)	2000-06-30
HUP0100611A2 (hu)	2001-09-28
US6465461B1 (en)	2002-10-15
WO1999032462A1 (fr)	1999-07-01

Publication	Publication Date	Title
MA24580A1 (fr)	1998-12-31	Composes dipeptidiques
MX208461B (es)	2002-06-19	Polisacaridos de termofraguado
DE69831625D1 (de)	2006-02-02	Gurtstraffer
PT1005446E (pt)	2004-06-30	Derivados de n-aroilfenilalanina
ID20287A (id)	1998-11-19	Resorsinil triazin
ATE250583T1 (de)	2003-10-15	Substituierte 3-cyanochinoline
DE69818203D1 (de)	2003-10-23	Werkzeughalter
DE69805048D1 (de)	2002-05-29	Photodiode
PT915088E (pt)	2003-01-31	Derivados de d-prolina
DE59804447D1 (de)	2002-07-18	Sicherheitsgurtaufroller
PT1003719E (pt)	2002-10-31	Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
BR9611570A (pt)	1999-03-30	Derivados de triazina
PT1027362E (pt)	2005-08-31	Derivados de cetolidos 2-halogeno-6-o-substituidos
EP1087957A4 (fr)	2003-01-02	Composes auto-inducteurs
DE59813487D1 (de)	2006-05-24	Substituierte 4-benzoyl-pyrazole
MA26681A1 (fr)	2004-12-20	Composes pyrazine
MA26587A1 (fr)	2004-12-20	Composes de triazine
PT966437E (pt)	2002-11-29	Derivados de 5-aroilnaftaleno
EP1056751A4 (fr)	2003-01-22	Composes boriques
DE59710430D1 (de)	2003-08-14	Substituierte 4-benzoyl-pyrazole
FI974453A0 (fi)	1997-12-08	Foerfarande foer foermedling av driftstyrningsfunktionerna foer ett telekommunikationssystem
FI973645A0 (fi)	1997-09-09	Foerfarande foer bestaemning av filtreringstiderna foer registeraoteranrop i ett telekommunikationssystem i samband med en V5-anslutning i olika nationella tillaempningar
ID24079A (id)	2000-07-06	Aminoheteroksiklilamida tersubstitusi
ATA187898A (de)	2002-02-15	Schliesszylinder
DE59807877D1 (de)	2003-05-15	Substituierte 4-benzoyl-pyrazole